Global Live & Dead Cell Viability Assay Kit Market Research Report 2023

Live & Dead Cell Viability Assay Kit Market

Live/Dead Cell Viability Assay Kit to evaluate cell viability and cell density.The Live-Dead Cell Viability Assay Kit is a quick and simple three-color

assay to measure cell viability.

The global Live & Dead Cell Viability Assay Kit market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Live & Dead Cell Viability Assay Kit is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Live & Dead Cell Viability Assay Kit is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Live & Dead Cell Viability Assay Kit in Clinical is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Live & Dead Cell Viability Assay Kit include Thermo Fisher Scientific, Merck, GeneCopoeia, Enzo Biochem, Chondrex, Molecular Devices, Sangon Biotech and ABP Biosciences, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Live & Dead Cell Viability Assay Kit, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live & Dead Cell Viability Assay Kit.

The Live & Dead Cell Viability Assay Kit market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Live & Dead Cell Viability Assay Kit market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Live & Dead Cell Viability Assay Kit companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Scope of Live & Dead Cell Viability Assay Kit Market Report

Core Chapters

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Live & Dead Cell Viability Assay Kit Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Mammalian Cells

1.2.3 Yeast And Fungi

1.2.4 Bacteria

1.3 Market by Application

1.3.1 Global Live & Dead Cell Viability Assay Kit Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Clinical

1.3.3 Microbiology

1.3.4 Research Institute

1.3.5 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Live & Dead Cell Viability Assay Kit Market Perspective (2018-2029)

2.2 Live & Dead Cell Viability Assay Kit Growth Trends by Region

2.2.1 Global Live & Dead Cell Viability Assay Kit Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Live & Dead Cell Viability Assay Kit Historic Market Size by Region (2018-2023)

2.2.3 Live & Dead Cell Viability Assay Kit Forecasted Market Size by Region (2024-2029)

2.3 Live & Dead Cell Viability Assay Kit Market Dynamics

2.3.1 Live & Dead Cell Viability Assay Kit Industry Trends

2.3.2 Live & Dead Cell Viability Assay Kit Market Drivers

2.3.3 Live & Dead Cell Viability Assay Kit Market Challenges

2.3.4 Live & Dead Cell Viability Assay Kit Market Restraints

3.1 Global Top Live & Dead Cell Viability Assay Kit Players by Revenue

3.1.1 Global Top Live & Dead Cell Viability Assay Kit Players by Revenue (2018-2023)

3.1.2 Global Live & Dead Cell Viability Assay Kit Revenue Market Share by Players (2018-2023)

3.2 Global Live & Dead Cell Viability Assay Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Live & Dead Cell Viability Assay Kit Revenue

3.4 Global Live & Dead Cell Viability Assay Kit Market Concentration Ratio

3.4.1 Global Live & Dead Cell Viability Assay Kit Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Live & Dead Cell Viability Assay Kit Revenue in 2022

3.5 Live & Dead Cell Viability Assay Kit Key Players Head office and Area Served

3.6 Key Players Live & Dead Cell Viability Assay Kit Product Solution and Service

3.7 Date of Enter into Live & Dead Cell Viability Assay Kit Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Live & Dead Cell Viability Assay Kit Historic Market Size by Type (2018-2023)

4.2 Global Live & Dead Cell Viability Assay Kit Forecasted Market Size by Type (2024-2029)

5.1 Global Live & Dead Cell Viability Assay Kit Historic Market Size by Application (2018-2023)

5.2 Global Live & Dead Cell Viability Assay Kit Forecasted Market Size by Application (2024-2029)

6.1 North America Live & Dead Cell Viability Assay Kit Market Size (2018-2029)

6.2 North America Live & Dead Cell Viability Assay Kit Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Live & Dead Cell Viability Assay Kit Market Size by Country (2018-2023)

6.4 North America Live & Dead Cell Viability Assay Kit Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Live & Dead Cell Viability Assay Kit Market Size (2018-2029)

7.2 Europe Live & Dead Cell Viability Assay Kit Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Live & Dead Cell Viability Assay Kit Market Size by Country (2018-2023)

7.4 Europe Live & Dead Cell Viability Assay Kit Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size (2018-2029)

8.2 Asia-Pacific Live & Dead Cell Viability Assay Kit Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size by Region (2018-2023)

8.4 Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Live & Dead Cell Viability Assay Kit Market Size (2018-2029)

9.2 Latin America Live & Dead Cell Viability Assay Kit Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Live & Dead Cell Viability Assay Kit Market Size by Country (2018-2023)

9.4 Latin America Live & Dead Cell Viability Assay Kit Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size (2018-2029)

10.2 Middle East & Africa Live & Dead Cell Viability Assay Kit Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size by Country (2018-2023)

10.4 Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Detail

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific Live & Dead Cell Viability Assay Kit Introduction

11.1.4 Thermo Fisher Scientific Revenue in Live & Dead Cell Viability Assay Kit Business (2018-2023)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 Merck

11.2.1 Merck Company Detail

11.2.2 Merck Business Overview

11.2.3 Merck Live & Dead Cell Viability Assay Kit Introduction

11.2.4 Merck Revenue in Live & Dead Cell Viability Assay Kit Business (2018-2023)

11.2.5 Merck Recent Development

11.3 GeneCopoeia

11.3.1 GeneCopoeia Company Detail

11.3.2 GeneCopoeia Business Overview

11.3.3 GeneCopoeia Live & Dead Cell Viability Assay Kit Introduction

11.3.4 GeneCopoeia Revenue in Live & Dead Cell Viability Assay Kit Business (2018-2023)

11.3.5 GeneCopoeia Recent Development

11.4 Enzo Biochem

11.4.1 Enzo Biochem Company Detail

11.4.2 Enzo Biochem Business Overview

11.4.3 Enzo Biochem Live & Dead Cell Viability Assay Kit Introduction

11.4.4 Enzo Biochem Revenue in Live & Dead Cell Viability Assay Kit Business (2018-2023)

11.4.5 Enzo Biochem Recent Development

11.5 Chondrex

11.5.1 Chondrex Company Detail

11.5.2 Chondrex Business Overview

11.5.3 Chondrex Live & Dead Cell Viability Assay Kit Introduction

11.5.4 Chondrex Revenue in Live & Dead Cell Viability Assay Kit Business (2018-2023)

11.5.5 Chondrex Recent Development

11.6 Molecular Devices

11.6.1 Molecular Devices Company Detail

11.6.2 Molecular Devices Business Overview

11.6.3 Molecular Devices Live & Dead Cell Viability Assay Kit Introduction

11.6.4 Molecular Devices Revenue in Live & Dead Cell Viability Assay Kit Business (2018-2023)

11.6.5 Molecular Devices Recent Development

11.7 Sangon Biotech

11.7.1 Sangon Biotech Company Detail

11.7.2 Sangon Biotech Business Overview

11.7.3 Sangon Biotech Live & Dead Cell Viability Assay Kit Introduction

11.7.4 Sangon Biotech Revenue in Live & Dead Cell Viability Assay Kit Business (2018-2023)

11.7.5 Sangon Biotech Recent Development

11.8 ABP Biosciences

11.8.1 ABP Biosciences Company Detail

11.8.2 ABP Biosciences Business Overview

11.8.3 ABP Biosciences Live & Dead Cell Viability Assay Kit Introduction

11.8.4 ABP Biosciences Revenue in Live & Dead Cell Viability Assay Kit Business (2018-2023)

11.8.5 ABP Biosciences Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Live & Dead Cell Viability Assay Kit Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Mammalian Cells

    Table 3. Key Players of Yeast And Fungi

    Table 4. Key Players of Bacteria

    Table 5. Global Live & Dead Cell Viability Assay Kit Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Live & Dead Cell Viability Assay Kit Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Live & Dead Cell Viability Assay Kit Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Live & Dead Cell Viability Assay Kit Market Share by Region (2018-2023)

    Table 9. Global Live & Dead Cell Viability Assay Kit Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Live & Dead Cell Viability Assay Kit Market Share by Region (2024-2029)

    Table 11. Live & Dead Cell Viability Assay Kit Market Trends

    Table 12. Live & Dead Cell Viability Assay Kit Market Drivers

    Table 13. Live & Dead Cell Viability Assay Kit Market Challenges

    Table 14. Live & Dead Cell Viability Assay Kit Market Restraints

    Table 15. Global Live & Dead Cell Viability Assay Kit Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Live & Dead Cell Viability Assay Kit Market Share by Players (2018-2023)

    Table 17. Global Top Live & Dead Cell Viability Assay Kit Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live & Dead Cell Viability Assay Kit as of 2022)

    Table 18. Ranking of Global Top Live & Dead Cell Viability Assay Kit Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Live & Dead Cell Viability Assay Kit Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Live & Dead Cell Viability Assay Kit Product Solution and Service

    Table 22. Date of Enter into Live & Dead Cell Viability Assay Kit Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Live & Dead Cell Viability Assay Kit Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global Live & Dead Cell Viability Assay Kit Revenue Market Share by Type (2018-2023)

    Table 26. Global Live & Dead Cell Viability Assay Kit Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global Live & Dead Cell Viability Assay Kit Revenue Market Share by Type (2024-2029)

    Table 28. Global Live & Dead Cell Viability Assay Kit Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Live & Dead Cell Viability Assay Kit Revenue Market Share by Application (2018-2023)

    Table 30. Global Live & Dead Cell Viability Assay Kit Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Live & Dead Cell Viability Assay Kit Revenue Market Share by Application (2024-2029)

    Table 32. North America Live & Dead Cell Viability Assay Kit Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Live & Dead Cell Viability Assay Kit Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Live & Dead Cell Viability Assay Kit Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Live & Dead Cell Viability Assay Kit Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Live & Dead Cell Viability Assay Kit Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Live & Dead Cell Viability Assay Kit Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Live & Dead Cell Viability Assay Kit Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Live & Dead Cell Viability Assay Kit Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Live & Dead Cell Viability Assay Kit Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Thermo Fisher Scientific Company Detail

    Table 48. Thermo Fisher Scientific Business Overview

    Table 49. Thermo Fisher Scientific Live & Dead Cell Viability Assay Kit Product

    Table 50. Thermo Fisher Scientific Revenue in Live & Dead Cell Viability Assay Kit Business (2018-2023) & (US$ Million)

    Table 51. Thermo Fisher Scientific Recent Development

    Table 52. Merck Company Detail

    Table 53. Merck Business Overview

    Table 54. Merck Live & Dead Cell Viability Assay Kit Product

    Table 55. Merck Revenue in Live & Dead Cell Viability Assay Kit Business (2018-2023) & (US$ Million)

    Table 56. Merck Recent Development

    Table 57. GeneCopoeia Company Detail

    Table 58. GeneCopoeia Business Overview

    Table 59. GeneCopoeia Live & Dead Cell Viability Assay Kit Product

    Table 60. GeneCopoeia Revenue in Live & Dead Cell Viability Assay Kit Business (2018-2023) & (US$ Million)

    Table 61. GeneCopoeia Recent Development

    Table 62. Enzo Biochem Company Detail

    Table 63. Enzo Biochem Business Overview

    Table 64. Enzo Biochem Live & Dead Cell Viability Assay Kit Product

    Table 65. Enzo Biochem Revenue in Live & Dead Cell Viability Assay Kit Business (2018-2023) & (US$ Million)

    Table 66. Enzo Biochem Recent Development

    Table 67. Chondrex Company Detail

    Table 68. Chondrex Business Overview

    Table 69. Chondrex Live & Dead Cell Viability Assay Kit Product

    Table 70. Chondrex Revenue in Live & Dead Cell Viability Assay Kit Business (2018-2023) & (US$ Million)

    Table 71. Chondrex Recent Development

    Table 72. Molecular Devices Company Detail

    Table 73. Molecular Devices Business Overview

    Table 74. Molecular Devices Live & Dead Cell Viability Assay Kit Product

    Table 75. Molecular Devices Revenue in Live & Dead Cell Viability Assay Kit Business (2018-2023) & (US$ Million)

    Table 76. Molecular Devices Recent Development

    Table 77. Sangon Biotech Company Detail

    Table 78. Sangon Biotech Business Overview

    Table 79. Sangon Biotech Live & Dead Cell Viability Assay Kit Product

    Table 80. Sangon Biotech Revenue in Live & Dead Cell Viability Assay Kit Business (2018-2023) & (US$ Million)

    Table 81. Sangon Biotech Recent Development

    Table 82. ABP Biosciences Company Detail

    Table 83. ABP Biosciences Business Overview

    Table 84. ABP Biosciences Live & Dead Cell Viability Assay Kit Product

    Table 85. ABP Biosciences Revenue in Live & Dead Cell Viability Assay Kit Business (2018-2023) & (US$ Million)

    Table 86. ABP Biosciences Recent Development

    Table 87. Research Programs/Design for This Report

    Table 88. Key Data Information from Secondary Sources

    Table 89. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Live & Dead Cell Viability Assay Kit Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Live & Dead Cell Viability Assay Kit Market Share by Type: 2022 VS 2029

    Figure 3. Mammalian Cells Features

    Figure 4. Yeast And Fungi Features

    Figure 5. Bacteria Features

    Figure 6. Global Live & Dead Cell Viability Assay Kit Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Live & Dead Cell Viability Assay Kit Market Share by Application: 2022 VS 2029

    Figure 8. Clinical Case Studies

    Figure 9. Microbiology Case Studies

    Figure 10. Research Institute Case Studies

    Figure 11. Other Case Studies

    Figure 12. Live & Dead Cell Viability Assay Kit Report Years Considered

    Figure 13. Global Live & Dead Cell Viability Assay Kit Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Live & Dead Cell Viability Assay Kit Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Live & Dead Cell Viability Assay Kit Market Share by Region: 2022 VS 2029

    Figure 16. Global Live & Dead Cell Viability Assay Kit Market Share by Players in 2022

    Figure 17. Global Top Live & Dead Cell Viability Assay Kit Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live & Dead Cell Viability Assay Kit as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Live & Dead Cell Viability Assay Kit Revenue in 2022

    Figure 19. North America Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Live & Dead Cell Viability Assay Kit Market Share by Country (2018-2029)

    Figure 21. United States Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Live & Dead Cell Viability Assay Kit Market Share by Country (2018-2029)

    Figure 25. Germany Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Live & Dead Cell Viability Assay Kit Market Share by Region (2018-2029)

    Figure 33. China Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Live & Dead Cell Viability Assay Kit Market Share by Country (2018-2029)

    Figure 41. Mexico Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Live & Dead Cell Viability Assay Kit Market Share by Country (2018-2029)

    Figure 45. Turkey Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Live & Dead Cell Viability Assay Kit Business (2018-2023)

    Figure 48. Merck Revenue Growth Rate in Live & Dead Cell Viability Assay Kit Business (2018-2023)

    Figure 49. GeneCopoeia Revenue Growth Rate in Live & Dead Cell Viability Assay Kit Business (2018-2023)

    Figure 50. Enzo Biochem Revenue Growth Rate in Live & Dead Cell Viability Assay Kit Business (2018-2023)

    Figure 51. Chondrex Revenue Growth Rate in Live & Dead Cell Viability Assay Kit Business (2018-2023)

    Figure 52. Molecular Devices Revenue Growth Rate in Live & Dead Cell Viability Assay Kit Business (2018-2023)

    Figure 53. Sangon Biotech Revenue Growth Rate in Live & Dead Cell Viability Assay Kit Business (2018-2023)

    Figure 54. ABP Biosciences Revenue Growth Rate in Live & Dead Cell Viability Assay Kit Business (2018-2023)

    Figure 55. Bottom-up and Top-down Approaches for This Report

    Figure 56. Data Triangulation

    Figure 57. Key Executives Interviewed